Cargando…

Serum soluble B7-H3 is a prognostic marker for patients with non-muscle-invasive bladder cancer

BACKGROUND: B7-H3 is a member of the B7 family of immune-regulatory ligands and is a costimulatory molecule promoting the T cell response in vitro. We herein investigated the clinical utility of serum soluble B7-H3 (sB7-H3) in patients with non-muscle invasive bladder cancer (NMIBC). METHODS: We ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azuma, Takeshi, Sato, Yujiro, Ohno, Tatsukuni, Azuma, Miyuki, Kume, Haruki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732087/ https://www.ncbi.nlm.nih.gov/pubmed/33306717 http://dx.doi.org/10.1371/journal.pone.0243379

Ejemplares similares

Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma
por: Azuma, Takeshi, et al.
Publicado: (2018)

Progress and Current Status in Hajdu-Cheney Syndrome with Focus on Novel Genetic Research
por: Aida, Natsuko, et al.
Publicado: (2022)

Overexpression of PD‐L1 in gingival basal keratinocytes reduces periodontal inflammation in a ligature‐induced periodontitis model
por: Wongtim, Keeratika, et al.
Publicado: (2021)

Systemic administration of a TLR7 agonist attenuates regulatory T cells by dendritic cell modification and overcomes resistance to PD-L1 blockade therapy
por: Nishii, Naoto, et al.
Publicado: (2018)

Small interfering RNA against CD86 during allergen challenge blocks experimental allergic asthma
por: Asai-Tajiri, Yukari, et al.
Publicado: (2014)

Comparison of reduced field-of-view DWI and full field-of view DWI for the differentiation between non-muscle invasive bladder cancer and muscle invasive bladder cancer using VI-RADS
por: Juri, Hiroshi, et al.
Publicado: (2022)

Triple‐marker immunohistochemical assessment of muscle‐invasive bladder cancer: Is there prognostic significance?
por: Labban, Muhieddine, et al.
Publicado: (2021)

Metastatic Renal Cell Carcinoma Change Vascularity
por: Azuma, Takeshi, et al.
Publicado: (2012)

Spontaneous regression of a renal mass and multiple lung nodules after methotrexate cessation
por: Iwaki, Takuya, et al.
Publicado: (2018)

Serum metabolites as early detection markers of non-muscle invasive bladder cancer in Chinese patients
por: Zhao, Yi, et al.
Publicado: (2023)

NXPH4 Used as a New Prognostic and Immunotherapeutic Marker for Muscle-Invasive Bladder Cancer
por: Gui, Zhiming, et al.
Publicado: (2022)

ras gene alterations in invasive and non-invasive rat bladder carcinomas induced by N-methyl-N-nitrosourea.
por: Yura, Y., et al.
Publicado: (1991)

Low expression of protocadherin7 (PCDH7) is a potential prognostic biomarker for primary non-muscle invasive bladder cancer
por: Lin, Ying-Li, et al.
Publicado: (2016)

mRNA Expression of S100A8 as a Prognostic Marker for Progression of Non-Muscle-Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2010)

Involvement of haptoglobin phenotypes and genotypes in non-muscle invasive bladder cancer: A possible prognostic marker for risk stratification
por: Aghaalikhani, Nazi, et al.
Publicado: (2020)

Integrative Transcriptome Profiling Reveals SKA3 as a Novel Prognostic Marker in Non-Muscle Invasive Bladder Cancer
por: You, Chaelin, et al.
Publicado: (2021)

Prognostic value of prostate volume in non-muscle invasive bladder cancer
por: Ham, Won Sik, et al.
Publicado: (2021)

Exploration of Prognostic Biomarkers of Muscle-Invasive Bladder Cancer (MIBC) by Bioinformatics
por: Xu, Xianglai, et al.
Publicado: (2021)

Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
por: Katayama, Satoshi, et al.
Publicado: (2022)

The prognostic impact of tumor necrosis in non-muscle invasive bladder cancer
por: Culpan, Meftun, et al.
Publicado: (2022)

Bladder cancer prospective cohort study on high‐risk non‐muscle invasive bladder cancer after photodynamic diagnosis‐assisted transurethral resection of the bladder tumor (BRIGHT study)
por: Kobayashi, Keita, et al.
Publicado: (2022)

Contributions of Interleukin‐33 and TSLP in a papain‐soaked contact lens‐induced mouse conjunctival inflammation model
por: Sugita, Jobu, et al.
Publicado: (2017)

Ultra-early versus early salvage androgen deprivation therapy for post-prostatectomy biochemical recurrence in pT2-4N0M0 prostate cancer
por: Taguchi, Satoru, et al.
Publicado: (2014)

Serum alanine aminotransferase as an early marker of outcomes in patients receiving anti-PD-1 or anti-CTLA-4 antibody
por: Azuma, Takeshi, et al.
Publicado: (2021)

FAM70B as a Novel Prognostic Marker for Cancer Progression and Cancer-Specific Death in Muscle-Invasive Bladder Cancer
por: Kang, Ho-Won, et al.
Publicado: (2012)

Preoperative Systemic Inflammatory Markers as a Significant Prognostic Factor After TURBT in Patients with Non-Muscle-Invasive Bladder Cancer
por: Ding, Li, et al.
Publicado: (2023)

Preoperative systemic inflammation response index is an independent prognostic marker for BCG immunotherapy in patients with non‐muscle‐invasive bladder cancer
por: Ye, Kun, et al.
Publicado: (2022)

Inflammatory Markers and Thromboembolic Risk in Patients with Non-Muscle-Invasive Bladder Cancer
por: Balan, Daniel, et al.
Publicado: (2021)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

Paracrine IL-33 Stimulation Enhances Lipopolysaccharide-Mediated Macrophage Activation
por: Ohno, Tatsukuni, et al.
Publicado: (2011)

Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer
por: El Demery, Mounira, et al.
Publicado: (2014)

TERT C228T mutation in non‐malignant bladder urothelium is associated with intravesical recurrence for patients with non‐muscle invasive bladder cancer
por: Hayashi, Yujiro, et al.
Publicado: (2020)

Serum microRNAs as predictors of risk for non-muscle invasive bladder cancer
por: Lian, Jie, et al.
Publicado: (2018)

Serum Levels of Soluble CD26, A Novel Prognostic Marker for Hepatitis E Infection
por: Rafiei, Alireza, et al.
Publicado: (2016)

Serum soluble Fas ligand is a severity and mortality prognostic marker for COVID-19 patients
por: Saleki, Kiarash, et al.
Publicado: (2022)

Prognostic Implications of Deep Muscle Invasion and High Grade for Bladder Urothelial Carcinoma
por: Hashmi, Atif A, et al.
Publicado: (2020)

The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer
por: Zhang, Jingqi, et al.
Publicado: (2020)

Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer
por: Quhal, Fahad, et al.
Publicado: (2021)

Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer
por: AZhaTi, BaiHeTiYa, et al.
Publicado: (2022)

Comment on “The prognostic impact of tumor necrosis in non-muscle invasive bladder cancer”
por: Wang, Dexin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qqt3e31u99vqvmnsotpc2d5a5a